arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ACCURAY INC

ARAY
$0.29 0.00 (+1.75%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Bearish
auto_awesome

Analytical Summary

ACCURAY INC faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $29.8M
Dividend Yield
Revenue Growth 2.7%
Op. Margin 1.7%
ROIC -5.1%
FCF / Share $-0.01
Trailing P/E
Price / Book 0.4x
FCF Yield
Debt / Equity 1.84
info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$458.50M
↑ +2.7%
Net Income Profit after all expenses
$-1.59M
↑ +89.8%
Operating Margin Operating profit as % of sales
1.7%
↑ +1414.8% 33th
FCF / Share Free cash flow per share
$-0.01
↑ +91.3%
Long-Term Debt Long-term obligations
$136.52M
↓ -20.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability
29
Returns
41
Financial Health
32
Cash Quality
60

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 65 quarters